In summary, the current review focused on SIRT1/PGC-1α/PPAR-γ as a possible mechanism underlying hypoxia-induced chemoresistance in NSCLC at the epigenetic and metabolic microenvironment level. The gene discussed is SIRT1; the disease is non-small cell lung carcinoma.